HUE059011T2 - Immunmodulátorként szolgáló ABC5-pozitív mezenchimális õssejtek - Google Patents

Immunmodulátorként szolgáló ABC5-pozitív mezenchimális õssejtek

Info

Publication number
HUE059011T2
HUE059011T2 HUE14168199A HUE14168199A HUE059011T2 HU E059011 T2 HUE059011 T2 HU E059011T2 HU E14168199 A HUE14168199 A HU E14168199A HU E14168199 A HUE14168199 A HU E14168199A HU E059011 T2 HUE059011 T2 HU E059011T2
Authority
HU
Hungary
Prior art keywords
abc5
immunomodulators
stem cells
mesenchymal stem
positive mesenchymal
Prior art date
Application number
HUE14168199A
Other languages
English (en)
Inventor
Markus Frank
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Publication of HUE059011T2 publication Critical patent/HUE059011T2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HUE14168199A 2006-05-31 2007-05-31 Immunmodulátorként szolgáló ABC5-pozitív mezenchimális õssejtek HUE059011T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80940706P 2006-05-31 2006-05-31

Publications (1)

Publication Number Publication Date
HUE059011T2 true HUE059011T2 (hu) 2022-09-28

Family

ID=38594403

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14168199A HUE059011T2 (hu) 2006-05-31 2007-05-31 Immunmodulátorként szolgáló ABC5-pozitív mezenchimális õssejtek

Country Status (13)

Country Link
US (4) US8455245B2 (hu)
EP (2) EP2035549B1 (hu)
AU (1) AU2007254894B9 (hu)
CA (1) CA2685492C (hu)
DK (2) DK2772535T3 (hu)
ES (2) ES2511791T3 (hu)
HK (2) HK1129703A1 (hu)
HU (1) HUE059011T2 (hu)
LT (1) LT2772535T (hu)
PL (2) PL2772535T3 (hu)
PT (2) PT2772535T (hu)
SI (2) SI2772535T1 (hu)
WO (1) WO2007143139A1 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2338756T3 (es) * 2000-06-05 2010-05-12 The Brigham And Women's Hospital, Inc. Un gen que codifica un homologo de glicoproteina p humana multifarmaco-resistente en el cromosoma 7p15-21 y usos del mismo.
PL2772535T3 (pl) * 2006-05-31 2022-09-05 Children's Medical Center Corporation Mezenchymalne komórki macierzyste ABC5 dodatnie jako immunomodulatory
PT2155248E (pt) 2007-04-12 2015-10-23 Brigham & Womens Hospital Direcionamento a abcb5 para tratameto do cancro
US11542328B2 (en) 2008-11-14 2023-01-03 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
ES2796111T3 (es) 2008-11-14 2020-11-25 Brigham & Womens Hospital Inc Métodos terapéuticos relacionados con células madre cancerosas
JP7027026B2 (ja) * 2013-02-19 2022-03-01 ザ チルドレンズ メディカル センター コーポレーション 眼疾患を処置するためのａｂｃｂ５（＋）幹細胞
KR102319899B1 (ko) 2013-05-10 2021-11-01 칠드런'즈 메디컬 센터 코포레이션 상처 치유 및 조직 공학
US20150310380A1 (en) * 2014-04-28 2015-10-29 Patent Investment & Licensing Company Dispatch system having control shared with dispatched service providers
KR101723265B1 (ko) * 2013-08-16 2017-04-04 가톨릭대학교 산학협력단 mTOR/STAT3 신호억제제 처리된 면역조절능을 갖는 간엽줄기세포 및 이를 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물
WO2015088414A1 (en) * 2013-12-13 2015-06-18 Isletone Ab Immunomodulatory compositions
WO2015148512A1 (en) 2014-03-24 2015-10-01 Qt Holdings Corp Shaped articles including hydrogels and methods of manufacture and use thereof
US9790467B2 (en) * 2015-09-22 2017-10-17 Qt Holdings Corp Methods and compositions for activation or expansion of T lymphocytes
CN113301924A (zh) * 2018-08-18 2021-08-24 哈佛学院校长同事会 原位基因编辑
US20200061365A1 (en) * 2018-08-24 2020-02-27 Instant Systems, Inc. Cell storage container for use with sterile docking systems
BR112021019349A2 (pt) * 2019-03-28 2021-12-07 Childrens Medical Center Células-tronco preparadas altamente funcionais
AU2020263509A1 (en) * 2019-04-24 2021-11-11 Children's Medical Center Corporation ABCB5+ stem cell therapeutics for liver disease
US20230148432A1 (en) * 2020-03-30 2023-05-11 Children's Medical Center Corporation Use of stem cells for treatment of excessive inflammation
WO2022241090A1 (en) * 2021-05-13 2022-11-17 Primegen Us, Inc. Methods and compositions for treating liver disease
US20230256065A1 (en) * 2022-02-16 2023-08-17 Elena RUSYN Autologous stem cell vaccine and methods
CN115260098B (zh) * 2022-06-09 2024-06-04 澳门科技大学 Abcb5抑制剂在制备多耐药性类风湿性关节炎治疗药物中的应用

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
DE3587465T2 (de) 1984-09-10 1994-01-20 Hsc Res Dev Corp Vielfache Drogen-Resistenz in Säugetierzellinien und Isolierung der determinanten Glykoprotein-DNS.
US4837306A (en) 1985-02-25 1989-06-06 The Ontario Cancer Institute Method for selecting hybridomas producing antibodies specific to the P-glycoprotein cell suface antigen and a cDNA clone encoding the C-terminal portion of the antigen
US5837258A (en) 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
IT1257893B (it) 1992-06-17 1996-02-16 Ist Superiore Sanita Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteina umana.
WO1994009363A1 (en) 1992-10-14 1994-04-28 Board Of Regents, The University Of Texas System Cancer diagnosis and therapy
US5906934A (en) 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
AU731468B2 (en) 1996-04-19 2001-03-29 Mesoblast International Sarl Regeneration and augmentation of bone using mesenchymal stem cells
US6152142A (en) 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
WO1999046366A1 (en) * 1998-03-13 1999-09-16 Osiris Therapeutics, Inc. Uses for humane non-autologous mesenchymal stem cells
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
PT1066060E (pt) 1998-04-03 2003-12-31 Osiris Therapeutics Inc Celulas estaminais mesenquimais como imunossupressores
GB9808836D0 (en) 1998-04-27 1998-06-24 Amersham Pharm Biotech Uk Ltd Microfabricated apparatus for cell based assays
DE69936720T2 (de) 1998-05-29 2008-04-30 Osiris Therapeutics, Inc. Menschliche cd45+ und/oder fibroblasten+ mesenchymale stammzellen
ES2338756T3 (es) 2000-06-05 2010-05-12 The Brigham And Women's Hospital, Inc. Un gen que codifica un homologo de glicoproteina p humana multifarmaco-resistente en el cromosoma 7p15-21 y usos del mismo.
PL208113B1 (pl) 2000-06-22 2011-03-31 Genentech Inc Agonistyczne przeciwciało monoklonalne anty-trkC, mysie agonistyczne przeciwciało monoklonalne, ludzkie agonistyczne przeciwciało monoklonalne, wyizolowana cząsteczka kwasu nukleinowego kodująca mysie agonistyczne przeciwciało monoklonalne, wyizolowana cząsteczka kwasu nukleinowego kodująca ludzkie przeciwciało anty-trkC, cząsteczka kwasu nukleinowego, linia komórek gospodarza, linia komórek hybrydomy, przeciwciało wytwarzane przez tę linię komórek hybrydomy, wyizolowana cząsteczka kwasu nukleinowego i wektor zawierający tę cząsteczkę kwasu nukleinowego, przeciwciało, polipeptyd, kompozycja
SE517275C2 (sv) * 2000-09-20 2002-05-21 Obducat Ab Sätt vid våtetsning av ett substrat
CA2427010A1 (en) 2000-10-27 2002-05-23 Incyte Genomics, Inc. Transporters and ion channels
US6905678B2 (en) 2001-07-07 2005-06-14 Crucell Holland B.V. Gene delivery vectors with cell type specificity for mesenchymal stem cells
ATE481985T1 (de) 2002-07-03 2010-10-15 Ono Pharmaceutical Co Immunpotenzierende zusammensetzungen
ES2367430T3 (es) 2002-12-23 2011-11-03 Wyeth Llc Anticuerpos contra pd-1 y sus usos.
GB0325130D0 (en) 2003-10-28 2003-12-03 Smith & Nephew Apparatus with scaffold
AU2004295680A1 (en) 2003-11-24 2005-06-16 The Rockefeller University A method for isolating a self-renewing, multipotent slow-cycling cell
CN107090034B (zh) 2004-01-07 2021-10-01 诺华疫苗和诊断公司 M-csf特异性单克隆抗体及其应用
US20050186672A1 (en) 2004-01-27 2005-08-25 Reliance Life Sciences Pvt. Ltd. Tissue system with undifferentiated stem cells derived from corneal limbus
CA2629330C (en) 2004-11-12 2018-05-22 Cambridge University Technical Services Ltd. Methods and means related to cancer stem cells
WO2006103685A2 (en) 2005-03-28 2006-10-05 Vision Research Foundation A method for cultivating cells derived from corneal limbal tissue and cells deived from corneal limbal tissue
CN101330830B (zh) * 2005-10-18 2016-01-20 国家犹太健康中心 条件无限增殖化长期干细胞和制备和使用所述细胞的方法
PL2772535T3 (pl) 2006-05-31 2022-09-05 Children's Medical Center Corporation Mezenchymalne komórki macierzyste ABC5 dodatnie jako immunomodulatory
EP2526969A1 (en) 2006-09-07 2012-11-28 Stemline Therapeutics, Inc. Monitoring cancer stem cells
PT2155248E (pt) 2007-04-12 2015-10-23 Brigham & Womens Hospital Direcionamento a abcb5 para tratameto do cancro
US9011840B2 (en) 2008-03-14 2015-04-21 The Board Of Trustees Of The University Of Illinois Activated mesenchymal stem cells for wound healing and impaired tissue regeneration
ES2796111T3 (es) 2008-11-14 2020-11-25 Brigham & Womens Hospital Inc Métodos terapéuticos relacionados con células madre cancerosas
US11542328B2 (en) 2008-11-14 2023-01-03 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
JP7027026B2 (ja) 2013-02-19 2022-03-01 ザ チルドレンズ メディカル センター コーポレーション 眼疾患を処置するためのａｂｃｂ５（＋）幹細胞
KR102319899B1 (ko) 2013-05-10 2021-11-01 칠드런'즈 메디컬 센터 코포레이션 상처 치유 및 조직 공학
MX2020011297A (es) 2018-04-25 2020-11-18 Childrens Medical Center Ligandos y substratos de abcb5.
BR112021019349A2 (pt) 2019-03-28 2021-12-07 Childrens Medical Center Células-tronco preparadas altamente funcionais

Also Published As

Publication number Publication date
ES2918323T3 (es) 2022-07-15
PL2772535T3 (pl) 2022-09-05
SI2035549T1 (sl) 2015-03-31
AU2007254894B9 (en) 2014-11-13
US11624054B2 (en) 2023-04-11
HK1201295A1 (en) 2015-08-28
EP2772535B1 (en) 2022-04-06
US8455245B2 (en) 2013-06-04
DK2035549T3 (da) 2014-10-13
PT2035549E (pt) 2014-10-06
CA2685492A1 (en) 2007-12-13
DK2772535T3 (da) 2022-07-04
HK1129703A1 (en) 2009-12-04
US20080003206A1 (en) 2008-01-03
PT2772535T (pt) 2022-07-04
US10017738B2 (en) 2018-07-10
PL2035549T3 (pl) 2014-12-31
EP2772535A1 (en) 2014-09-03
EP2035549A1 (en) 2009-03-18
AU2007254894B2 (en) 2014-10-23
EP2035549B1 (en) 2014-07-09
CA2685492C (en) 2018-01-16
US20230313136A1 (en) 2023-10-05
US20180320131A1 (en) 2018-11-08
AU2007254894A1 (en) 2007-12-13
LT2772535T (lt) 2022-08-25
US20130315880A1 (en) 2013-11-28
ES2511791T3 (es) 2014-10-23
WO2007143139A1 (en) 2007-12-13
SI2772535T1 (sl) 2022-08-31

Similar Documents

Publication Publication Date Title
HK1201295A1 (en) Abc5 positive mesenchymal stem cells as immunomodulators abc5
HK1216883A1 (zh) 幹細胞培養
PL2254586T3 (pl) Cząstki mezenchymalnych komórek macierzystych
EP2315829A4 (en) INDUCED PLURIPOTENT STEM CELLS
PL2046946T3 (pl) Hodowla pluripotencjalnych komórek macierzystych
GB2458863B (en) Improved culture of stem cells
GB0814249D0 (en) Uses of mesenchymal stem cells
SG10201500674YA (en) Pluripotent stem cells
EP1971679A4 (en) MESENCHYMAL STEM CELLS EXPRESSING TNF RECEPTOR
IL212368A0 (en) Compounds that expand hematopoietic stem cells
ZA201000715B (en) Single pluripotent stem cell culture
SG10201403202XA (en) Pre-natal mesenchymal stem cells
EP2007411A4 (en) REGULATORY STEM CELLS
EP2294182A4 (en) CULTS OF MULTIPOTENT STEM CELLS
EP2037960A4 (en) METHOD FOR MANIPULATING STEM CELLS
GB0602208D0 (en) Embryonic stem cells
GB0724994D0 (en) Mesenchymal stem cell markers
GB0818256D0 (en) stem cells
GB2467284B (en) Sulfatase enzymes
GB0918471D0 (en) Stem cells
IL193947A0 (en) Regulating stem cells